Optometry Times

Optometry Times Practical chairside advice Posting Policy:
Thank you for liking the official Optometry Times page. We're glad you're here.

We are committed to creating a community that encourages self-expression and mirrors the values of Optometry Times including respect for the rights, dignity, and property of others. We ask all fans to do their part to help us achieve the goal. In doing that, we ask you not to post content that:
-is threatening, abusive, obscene, indecent, or objectionable.
-is deceptive, false, or misleading
-viol

ates the intellectual property rights of other people
-is illegal
-references a third party website or is self-promoting spam
-is inappropriate, offensive, or hateful
We reserve the right to remove any content or block users that violate our community guidelines, or that we determine are otherwise offensive to our community. All content must also comply with Facebook's policies as well. We would be sorry to see you go, but if you change your mind and no longer want to like our page, please feel free to "unlike" our page.

Kaleb Abbott, OD, MS, FAAO, FOWNS; and Andrew Pucker, OD, PhD, FAAO, FSLS, FBCLA, are advocating for refreshed terminolo...
12/17/2025

Kaleb Abbott, OD, MS, FAAO, FOWNS; and Andrew Pucker, OD, PhD, FAAO, FSLS, FBCLA, are advocating for refreshed terminology when it comes to artificial drops. In an opinion article published in The Ocular Surface titled “It's Time to Retire the Terms Artificial Tears and Rewetting Drops: A Call for Accurate Terminology and Updated Clinical Usage in Eye Care,” the doctors stated that the term artificial tears does not accurately reflect the role that eye drops play in lubricating the eyes and misrepresents these drops as replacements for the natural tear film.

Read more: https://hubs.li/Q03Yc2sW0

A new consensus report published in JAMA Ophthalmology described new experimental oncology drug–related ocular adverse e...
12/15/2025

A new consensus report published in JAMA Ophthalmology described new experimental oncology drug–related ocular adverse event grading scales that were compiled with the goals of achieving conciseness and the ability to provide clear drug-dose-modification recommendations compared with the previous ocular Common Terminology Criteria for Adverse Events (CTCAE) scale, according to the study authors. Neel D. Pasricha, MD, from the Department of Ophthalmology and the Francis I. Proctor Foundation, University of California, San Francisco, was the lead study author.

Read more: https://hubs.li/Q03Yc16z0

With another successful year in eye care is coming to a close, Optometry Times took this opportunity to learn about opto...
12/15/2025

With another successful year in eye care is coming to a close, Optometry Times took this opportunity to learn about optometrists’ view of the future and their vision for exciting developments in 2026. Their responses covered a broad range of topics.

Watch here: https://hubs.ly/Q03Yc89s0

There's been plenty of OSD news this week! Get caught up on the latest with our weekly update: https://hubs.li/Q03X6P--0
12/06/2025

There's been plenty of OSD news this week! Get caught up on the latest with our weekly update: https://hubs.li/Q03X6P--0

11/27/2025

Grateful for the eye-care professionals who bring clarity, comfort, and better vision to patients every day. Wishing you a spec-tacular 👓 and restorative Thanksgiving! 🦃

We have begun rolling out our Crafting Your Own Eyewear series with Dr Diana Canto-Sims! Check out our landing page to w...
11/26/2025

We have begun rolling out our Crafting Your Own Eyewear series with Dr Diana Canto-Sims! Check out our landing page to watch video interviews with 4 companies that specialize in helping optometric practices launch their own brands: https://hubs.ly/Q03Vf6LF0

The recent American Academy of Optometry (AAO) 2025 annual meeting in Boston offered attendees some insights into clinic...
11/25/2025

The recent American Academy of Optometry (AAO) 2025 annual meeting in Boston offered attendees some insights into clinicians’ thoughts about the conference. Optometry Times presented clinicians with a question about their practices.

Some optometrists replied that they had the opportunity to learn something new through the AAO’s revamping of its available continuing education.

Others reported that AAO introduced them to the latest and greatest outside of their specialties.

Read more: https://hubs.li/Q03T-wX60

Nearly 2 years of continued bargaining efforts between the American Federation of State, County and Municipal Employees ...
11/24/2025

Nearly 2 years of continued bargaining efforts between the American Federation of State, County and Municipal Employees (AFSCME) 3299 and the University of California (UC) initially commenced, strikes will take place on November 17 and 18, 2025, at multiple UC locations. The strikes follow a potential conclusion to recent bargaining efforts between University Professional and Technical Employees-Communications Workers of America (UPTE-CWA) 9119 and UC, with a tentative agreement reached by both parties on November 8, according to an announcement made by UPTE.

Read more: https://hubs.li/Q03T-tM-0

Signals that originate from the vestibular system of the inner ear stabilize the retinal images as the body moves and th...
11/21/2025

Signals that originate from the vestibular system of the inner ear stabilize the retinal images as the body moves and the head tilts. The brain circuit in the so-called vestibulo-ocular reflex facilitates an individual’s stable perception of his or her surroundings. This phenomenon happens early in development. However, investigators who conducted a recent study identified an unexpected finding: Sensory input was not necessary for maturation of the reflex circuit in newborns.

Read more: https://hubs.li/Q03T-g-00

A new post-hoc analysis of the Age-Related Eye Disease Study 2 showed that the natural history data and multivariable mo...
11/20/2025

A new post-hoc analysis of the Age-Related Eye Disease Study 2 showed that the natural history data and multivariable models may be helpful in clinical practice and trials. While the risk factors for the first development of GA lesions, the subsequent incidence rate of the lesions, and area-based progression overlapped only partially, the investigators reported that their mechanisms may be partially distinct, which has an impact on potential therapeutic approaches.

Read more: https://hubs.li/Q03SS7cC0

My Eyes, an Australian feature written, produced, and led by optometrist and filmmaker Tsu Shan Chambers, was shaped by ...
11/19/2025

My Eyes, an Australian feature written, produced, and led by optometrist and filmmaker Tsu Shan Chambers, was shaped by a 5-year development process grounded in real experiences. Speaking with the Eye Care Network, Chambers explained that the project traces back to her time volunteering at the Sydney 2000 Paralympic Games, where she served as a personal assistant to vision-impaired judo athletes while she was an optometry student. “It actually came about when I volunteered at the Paralympic Games… and I was actually the personal assistant to the vision-impaired judo athletes,” she recalled.

Watch the interview: https://hubs.li/Q03SRZx20

Topline results that were recently released from Sydnexis’s phase 3 Study of Atropine for the Reduction of Myopia Progre...
11/18/2025

Topline results that were recently released from Sydnexis’s phase 3 Study of Atropine for the Reduction of Myopia Progression (STAR) trial of SYD-101 (atropine 0.01%) for slowing the progression of myopia in children demonstrated that the trial met its primary efficacy and key secondary end points. The primary efficacy end point was the proportion of patients with confirmed progression of -0.75 D at 36 months versus vehicle, (139 vs 111 patients (Vehicle vs. 0.01%); p=0.0226), with the secondary end point as mean myopic annual progression rate in the full study population at month 36 (vehicle: -0.38 D/year vs 0.01% -0.30 D/year (p=0.0002), according to a news release.

Read more: https://hubs.li/Q03SPwCT0

Address

24950 Country Club Boulevard, Ste 200
North Olmsted, OH
44070

Telephone

+14402438100

Website

Alerts

Be the first to know and let us send you an email when Optometry Times posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Optometry Times:

Shortcuts

Share

Category